
South Korea’s Shin Ramyun Finds a Wider Audience in Europe
Nongshim’s flagship instant noodle brand Shin Ramyun is gaining traction in France beyond its traditional base of Asian
Curated content that matters
Explore stories across diverse categories

Nongshim’s flagship instant noodle brand Shin Ramyun is gaining traction in France beyond its traditional base of Asian

Celltrion is accelerating its push into Europe’s biosimilar market as Omlyclo, its first-to-market omalizumab biosimilar, gains traction in

Two prominent South Korean actors are facing growing public scrutiny following media reports alleging aggressive tax practices involving
Hyundai Motor Group’s decision not to exercise its buyback option on its former Russian manufacturing plant is fueling
Photo=Motionelements South Korea’s benchmark Kospi index could advance to as high as 5,200 points this year as improving earnings momentum—led by the semiconductor sector—supports further gains, according to a market strategist. In a report released Monday, Han Ji-young of Kiwoom Securities said the current rally still has room to run, citing the likelihood of additional upward revisions to corporate earnings
(Photo=KT) A temporary waiver of early termination fees by KT, one of South Korea’s three dominant wireless carriers, has set off an abrupt burst of customer movement in the country’s mobile industry, exposing how tightly contractual penalties have constrained competition in a mature market. Industry data show that 198,190 subscribers switched carriers between Dec. 31 and Jan. 5, more than
(Photo=Hugel) For years, the American market for wrinkle treatments has been defined less by choice than by habit. Botox became shorthand for botulinum toxin itself, and most patients rarely asked what else was available. That dynamic is beginning to shift, as dermatology and aesthetic clinics look for products that better match changing patient expectations around natural results, pricing and long-term
(Photo=Dong-A ST) MetaVia, a U.S.-based clinical-stage biotechnology company affiliated with Dong-A ST, a South Korean pharmaceutical company, has released early clinical data suggesting that the next phase of obesity treatment may extend beyond GLP-1–only drugs that now dominate the U.S. market. In Phase 1b results disclosed this week, the company said its experimental therapy, DA-1726, demonstrated favorable safety and tolerability
Photo=Lakers SNS The Korean food giant is moving beyond jersey logos, embedding its brand in immersive Lakers game streams to tap into next-generation sports viewing and emotional engagement. In a strategic push to transform global brand visibility, CJ CheilJedang is betting that the future of sports marketing lies not just on the uniform, but inside the screen. The South Korean